China National Medicines Corporation Ltd. (SHA: 600511)
29.05
0.00 (0.00%)
Sep 6, 2024, 3:00 PM CST
China National Medicines Corporation Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 8,616 | 10,926 | 8,896 | 7,304 | 6,225 | 5,702 | Upgrade
|
Trading Asset Securities | - | - | - | 11.4 | - | - | Upgrade
|
Cash & Short-Term Investments | 8,616 | 10,926 | 8,896 | 7,316 | 6,225 | 5,702 | Upgrade
|
Cash Growth | 10.28% | 22.81% | 21.60% | 17.53% | 9.16% | 11.83% | Upgrade
|
Accounts Receivable | 15,106 | 12,881 | 12,550 | 13,392 | 12,507 | 12,075 | Upgrade
|
Other Receivables | 192.33 | 204 | 389.69 | 79.93 | 129.77 | 221.49 | Upgrade
|
Receivables | 15,298 | 13,085 | 12,940 | 13,472 | 12,637 | 12,297 | Upgrade
|
Inventory | 4,961 | 3,961 | 3,717 | 3,515 | 3,050 | 3,356 | Upgrade
|
Other Current Assets | 308.31 | 307.79 | 210.44 | 280.62 | 198.65 | 320.83 | Upgrade
|
Total Current Assets | 29,184 | 28,279 | 25,764 | 24,584 | 22,110 | 21,676 | Upgrade
|
Property, Plant & Equipment | 907.22 | 827.04 | 857.91 | 845.06 | 895.73 | 832.74 | Upgrade
|
Long-Term Investments | 1,928 | 1,907 | 1,623 | 1,365 | 1,141 | 933.49 | Upgrade
|
Goodwill | 203.77 | 203.77 | 203.77 | 203.77 | 203.77 | 203.77 | Upgrade
|
Other Intangible Assets | 264.66 | 258.11 | 262.92 | 258.65 | 256.12 | 263.78 | Upgrade
|
Long-Term Deferred Tax Assets | 137.99 | 123.87 | 124.37 | 115.94 | 100.6 | 106.99 | Upgrade
|
Long-Term Deferred Charges | 156.11 | 150.06 | 86.19 | 89.6 | 90.31 | 71.81 | Upgrade
|
Other Long-Term Assets | 772.51 | 703.57 | 686.95 | 548.08 | 108.13 | 105.06 | Upgrade
|
Total Assets | 33,554 | 32,453 | 29,609 | 28,010 | 24,905 | 24,194 | Upgrade
|
Accounts Payable | 11,923 | 10,943 | 9,917 | 10,058 | 8,990 | 9,404 | Upgrade
|
Accrued Expenses | 369.98 | 604.96 | 640.01 | 564.03 | 514.43 | 611.46 | Upgrade
|
Short-Term Debt | 239.71 | 268.35 | 252.06 | 428.83 | 471.83 | 348.92 | Upgrade
|
Current Portion of Leases | 96.34 | 74.08 | 80.5 | 75.81 | 70.12 | 42.21 | Upgrade
|
Current Income Taxes Payable | 48.26 | 113.17 | 84.89 | 112.18 | 76.99 | 107.59 | Upgrade
|
Current Unearned Revenue | 105.95 | 61.12 | 176.9 | 43.68 | 66.59 | 68.3 | Upgrade
|
Other Current Liabilities | 1,578 | 1,830 | 1,589 | 1,457 | 1,047 | 1,021 | Upgrade
|
Total Current Liabilities | 14,361 | 13,894 | 12,740 | 12,739 | 11,237 | 11,603 | Upgrade
|
Long-Term Leases | 281.17 | 205.08 | 182.57 | 197.29 | 260.09 | 166.62 | Upgrade
|
Long-Term Unearned Revenue | 42.42 | 46.06 | 46.35 | 42.66 | 45.53 | 39.54 | Upgrade
|
Long-Term Deferred Tax Liabilities | 27.54 | 26.78 | 33.47 | 35.39 | 40.84 | 46.43 | Upgrade
|
Other Long-Term Liabilities | 899.32 | 747.14 | 747.14 | 639.8 | 226.62 | 178.07 | Upgrade
|
Total Liabilities | 15,612 | 14,920 | 13,750 | 13,655 | 11,811 | 12,035 | Upgrade
|
Common Stock | 754.5 | 754.5 | 754.5 | 754.5 | 754.5 | 754.5 | Upgrade
|
Additional Paid-In Capital | 2,349 | 2,349 | 2,349 | 2,349 | 2,349 | 2,349 | Upgrade
|
Retained Earnings | 12,998 | 12,642 | 11,087 | 9,652 | 8,312 | 7,411 | Upgrade
|
Comprensive Income & Other | 22.21 | 30.74 | 24.04 | 24.91 | 27.69 | 22.45 | Upgrade
|
Total Common Equity | 16,123 | 15,776 | 14,215 | 12,780 | 11,444 | 10,537 | Upgrade
|
Minority Interest | 1,818 | 1,757 | 1,645 | 1,575 | 1,650 | 1,622 | Upgrade
|
Shareholders' Equity | 17,942 | 17,533 | 15,859 | 14,355 | 13,094 | 12,159 | Upgrade
|
Total Liabilities & Equity | 33,554 | 32,453 | 29,609 | 28,010 | 24,905 | 24,194 | Upgrade
|
Total Debt | 617.22 | 547.5 | 515.13 | 701.93 | 802.04 | 557.75 | Upgrade
|
Net Cash (Debt) | 7,999 | 10,378 | 8,381 | 6,614 | 5,423 | 5,144 | Upgrade
|
Net Cash Growth | 8.64% | 23.83% | 26.72% | 21.97% | 5.41% | 26.29% | Upgrade
|
Net Cash Per Share | 10.60 | 13.76 | 11.11 | 8.77 | 7.19 | 6.75 | Upgrade
|
Filing Date Shares Outstanding | 754.5 | 754.5 | 754.5 | 754.5 | 754.5 | 754.5 | Upgrade
|
Total Common Shares Outstanding | 754.5 | 754.5 | 754.5 | 754.5 | 754.5 | 754.5 | Upgrade
|
Working Capital | 14,823 | 14,385 | 13,025 | 11,845 | 10,872 | 10,073 | Upgrade
|
Book Value Per Share | 21.37 | 20.91 | 18.84 | 16.94 | 15.17 | 13.97 | Upgrade
|
Tangible Book Value | 15,655 | 15,314 | 13,748 | 12,318 | 10,984 | 10,070 | Upgrade
|
Tangible Book Value Per Share | 20.75 | 20.30 | 18.22 | 16.33 | 14.56 | 13.35 | Upgrade
|
Buildings | 408.84 | 408.84 | 433.49 | 387.18 | 381.37 | 388.93 | Upgrade
|
Machinery | 773.47 | 759.8 | 702.78 | 661.15 | 629.64 | 616.3 | Upgrade
|
Construction In Progress | 0.84 | 2.54 | 36.21 | 57.09 | 13.24 | 12.12 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.